Table 1.
Baseline clinical characteristics findings.
|
Total
(n = 156) |
Non-TCFA
(n = 113) |
TCFA
(n = 43) |
P-value | |
|---|---|---|---|---|
| Age, years | 65.29 ± 8.41 | 65.17 ± 8.34 | 65.63 ± 8.68 | 0.761 |
| Male, n (%) | 105 (67.3) | 79 (61.9) | 35 (81.4) | 0.021 |
| Smoker, n (%) | 89 (57.1) | 63 (55.8) | 26 (60.5) | 0.595 |
| CHD family history, n (%) | 90 (57.7) | 65 (57.5) | 25 (58.1) | 0.944 |
| Hypertension, n (%) |
83 (53.2) | 60 (53.1) | 23 (53.5) | 0.965 |
| Diabetes, n (%) | 48 (30.8) | 30 (26.5) | 18 (41.9) | 0.064 |
| Hyperlipidemia, n (%) |
56 (35.9) | 44 (38.9) | 12 (27.9) | 0.199 |
| SBP, mmHg | 134.31 ± 16.68 | 133.67 ± 16.44 | 136.00 ± 17.36 | 0.438 |
| DBP, mmHg | 79.99 ± 9.76 | 80.21 ± 9.82 | 79.40 ± 9.71 | 0.642 |
| TC, mmol/L | 4.13 ± 1.10 | 4.01 ± 1.01 | 4.44 ± 1.26 | 0.030 |
| TG, mmol/L | 1.62 ± 1.02 | 1.57 ± 1.03 | 1.73 ± 1.00 | 0.396 |
| LDL-C, mmol/L | 2.75 ± 1.04 | 2.73 ± 1.01 | 2.82 ± 1.05 | 0.631 |
| HDL-C, mmol/L | 1.11 ± 0.57 | 1.12 ± 0.52 | 1.11 ± 0.68 | 0.965 |
| Glucose, mmol/L | 6.21 ± 2.22 | 6.30 ± 2.30 | 5.97 ± 2.01 | 0.417 |
| HbA1c, (%) | 5.97 ± 1.00 | 5.99 ± 0.91 | 5.90 ± 1.22 | 0.590 |
| eGFR | 76.71 ± 19.03 | 76.33 ± 18.60 | 77.70 ± 20.31 | 0.690 |
| Treatment at discharge | ||||
| Anti-platelet, n (%) | 143 (91.7) | 105 (92.9) | 38 (88.4) | 0.358 |
| Statins, n (%) | 145 (92.9) | 104 (92.0) | 41 (95.3) | 0.470 |
| β-blockers, n (%) | 39 (25.0) | 27 (23.9) | 12 (27.9) | 0.605 |
| ACEI/ARB, n (%) | 72 (46.2) | 54 (47.8) | 18 (41.9) | 0.507 |
| CCB, n (%) | 50 (32.1) | 73 (32.1) | 13 (30.2) | 0.764 |
| Insulin, n (%) | 20 (12.8) | 14 (12.4) | 6 (14.0) | 0.794 |
| LTL (kb) | 13.51 (11.07, 15.49) | 13.81 (12.06, 16.11) | 11.95 (10.56, 15.21) | 0.003 |
Values were represented by mean ± SD or median and quartile (25%, 75%) and n (%).
CHD, coronary heart disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triacylglycerol; LDL-C, low-density lipoproteins-cholesterol; HDL-C, high-density lipoproteins-cholesterol; HbA1c, glycated hemoglobin; eGFR, estimated glomerular filtration rate; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CCB, calcium channel blocker; LTL, leukocyte telomere length.